Selegiline tablets

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved January 1997

Specific Treatments:

Parkinson’s disease

Therapeutic Areas

Find Related Trials for The Following Conditions

General Information

Selegiline has been approved for the treatment of Parkinson's disease. Selegiline is a generic equivalent of Somerset’s Eldepryl tablets, a drug for the treatment of Parkinson’s disease. Other generic versions of this product have been introduced over the last several months.